NL-OMON35531已完成不适用
A single-site, open-label study in healthy male subjects to compare rotigotine saliva and plasma concentrations in steady-state after multiple-dose application of rotigotine transdermal patch - Rotigotine transdermal patch study
CB Pharma0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •male; 18 - 25 years; BMI 19.0 - 28.0 kg/m2; no smoking; white skin.
排除标准
- •Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 3 months the screening for the study or being a blood donor within 3 months prior to the screening for the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
Single-center, open-label study in healthy male subjects to evaluate the absolute bioavailability of a 10 mg oral dose of vericiguat (BAY 1021189) (as IR tablets following a high-fat, high-calorie meal) in comparison to an intravenous, 14C-labeled micro-dose (20 µg) of vericiguat10019280heart failureNL-OMON42434Bayer HealthCare AG, Clinical Sciences10
已完成
不适用
Pharmacokinetic study of fermented red ginseng extractKCT0000735Chonbuk National University Hospital12
已完成
1 期
An Open-label, Single-dose, Non-randomized Study of IV 14C-labeled PER977 in Healthy Male SubjectsHealthyNCT02205905Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.6
招募中
不适用
A Single-Center, Prospective Study in Healthy Subjects to Validate a New OXYGEN RESERVE INDEX (ORI)zuurstofspanning en zuurstof saturatie bij gezonde vrijwilligersOxygen Reserve Indexpressure of O2NL-OMON41998MASIMO20
尚未招募
不适用
Validate a New OXYGEN RESERVE INDEX (ORI)NL-OMON20848MCG20